MANGALAM SEEDS
|
MANGALAM SEEDS Last 5 Year Financial Ratios History
[Consolidated]
| Mar2025 | Mar2024 | Mar2023 | Mar2022 | Mar2021 | |
|---|---|---|---|---|---|
| Operational & Financial Ratios | |||||
| Earnings Per Share (Rs) | 9.37 | 12.01 | 10.08 | 4.71 | 5.59 |
| CEPS(Rs) | 10.86 | 13.46 | 11.15 | 5.51 | 6.30 |
| DPS(Rs) | - | - | - | - | - |
| Book NAV/Share(Rs) | 72.82 | 63.53 | 51.57 | 41.35 | 36.57 |
| Tax Rate(%) | 17.64 | 17.04 | 17.05 | 16.25 | 14.34 |
| Margin Ratios | |||||
| Core EBITDA Margin(%) | 17.40 | 18.03 | 24.50 | 20.13 | 21.52 |
| EBIT Margin(%) | 16.25 | 16.71 | 22.75 | 18.05 | 19.67 |
| Pre Tax Margin(%) | 12.11 | 13.93 | 20.41 | 15.06 | 17.38 |
| PAT Margin (%) | 9.97 | 11.56 | 16.93 | 12.61 | 14.89 |
| Cash Profit Margin (%) | 11.56 | 12.95 | 18.72 | 14.78 | 16.79 |
| Performance Ratios | |||||
| ROA(%) | 6.93 | 12.36 | 15.22 | 8.53 | 12.03 |
| ROE(%) | 13.74 | 20.86 | 21.70 | 12.08 | 16.59 |
| ROCE(%) | 12.34 | 18.97 | 21.64 | 13.06 | 17.38 |
| Asset Turnover(x) | 0.70 | 1.07 | 0.90 | 0.68 | 0.81 |
| Sales/Fixed Asset(x) | 1.68 | 2.46 | 2.29 | 1.59 | 1.58 |
| Working Capital/Sales(x) | 3.16 | 4.04 | 2.32 | 2.20 | 2.48 |
| Efficiency Ratios | |||||
| Fixed Capital/Sales(x) | 0.60 | 0.41 | 0.44 | 0.63 | 0.63 |
| Receivable days | 71.53 | 53.43 | 72.66 | 94.26 | 91.65 |
| Inventory Days | 170.84 | 95.07 | 110.49 | 127.74 | 90.34 |
| Payable days | 12.35 | 5.62 | 5.09 | 11.93 | 20.62 |
| Valuation Parameters | |||||
| PER(x) | 17.44 | 21.18 | 16.10 | 18.22 | 12.52 |
| PCE(x) | 15.05 | 18.89 | 14.56 | 15.55 | 11.11 |
| Price/Book(x) | 2.24 | 4.00 | 3.15 | 2.07 | 1.91 |
| Yield(%) | - | - | - | - | - |
| EV/Net Sales(x) | 2.35 | 2.93 | 2.93 | 2.67 | 2.09 |
| EV/Core EBITDA(x) | 13.18 | 15.92 | 11.95 | 13.16 | 9.70 |
| EV/EBIT(x) | 14.47 | 17.25 | 12.89 | 14.74 | 10.63 |
| EV/CE(x) | 1.68 | 2.59 | 2.58 | 1.62 | 1.60 |
| M Cap / Sales | 1.74 | 2.48 | 2.73 | 2.30 | 1.87 |
| Growth Ratio | |||||
| Net Sales Growth(%) | -8.20 | 71.90 | 60.02 | -0.81 | 2.20 |
| Core EBITDA Growth(%) | -11.00 | 28.84 | 93.57 | -6.79 | 60.83 |
| EBIT Growth(%) | -12.13 | 28.23 | 101.02 | -8.75 | 58.13 |
| PAT Growth(%) | -21.98 | 19.08 | 114.25 | -15.82 | 63.79 |
| EPS Growth(%) | -21.98 | 19.08 | 114.25 | -15.82 | 63.79 |
| Financial Stability Ratios | |||||
| Total Debt/Equity(x) | 0.81 | 0.82 | 0.31 | 0.39 | 0.25 |
| Current Ratio(x) | 1.57 | 1.66 | 2.81 | 2.22 | 2.85 |
| Quick Ratio(x) | 0.55 | 0.76 | 1.46 | 1.00 | 1.74 |
| Interest Cover(x) | 3.93 | 6.00 | 9.75 | 6.02 | 8.61 |
| Total Debt/Mcap(x) | 0.36 | 0.20 | 0.10 | 0.19 | 0.13 |
Compare Financial Ratios of peers of MANGALAM SEEDS
| Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
| MANGALAM SEEDS | ₹163.8 Cr | 1.3% | -2.6% | -26.5% | Stock Analytics | |
| BOMBAY BURMAH TRADING CORPORATION | ₹12,797.2 Cr | -3.7% | -0.5% | -12.5% | Stock Analytics | |
| KAVERI SEED COMPANY | ₹5,034.1 Cr | 5.1% | 0.7% | 12.9% | Stock Analytics | |
| VENKYS (INDIA) | ₹2,090.8 Cr | 5.6% | 10.7% | -17.8% | Stock Analytics | |
| BOMBAY SUPER HYBRID SEEDS | ₹1,160.4 Cr | 10% | 0.3% | -23.4% | Stock Analytics | |
| INDO US BIOTECH | ₹245.7 Cr | -0.5% | -7.4% | -63.5% | Stock Analytics | |
MANGALAM SEEDS Share Price vs Sensex
| Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
| MANGALAM SEEDS | 1.3% |
-2.6% |
-26.5% |
| SENSEX | 0.7% |
0.5% |
9% |
You may also like the below Video Courses